Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,251 | -15,818 | -11,543 | -5,824 | -22,942 |
| Depreciation Amortization | 955 | 709 | 462 | 258 | 1,048 |
| Accounts receivable | N/A | N/A | -276 | -41 | N/A |
| Accounts payable and accrued liabilities | -419 | -165 | N/A | N/A | -103 |
| Other Working Capital | -215 | -217 | 220 | -1,198 | 1,667 |
| Other Operating Activity | 8,045 | 3,116 | 2,262 | 1,036 | 5,052 |
| Operating Cash Flow | $-15,885 | $-12,375 | $-8,875 | $-5,769 | $-15,278 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,208 | 8,708 | -938 | 2,000 | 13,460 |
| PPE Investments | N/A | N/A | N/A | N/A | -218 |
| Investing Cash Flow | $9,208 | $8,708 | $-938 | $2,000 | $13,242 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | -4 | -2 | -1 | -7 |
| Common Stock Issued | 9,179 | 9,179 | 9,244 | 54 | N/A |
| Financing Cash Flow | $9,174 | $9,175 | $9,242 | $53 | $-7 |
| Beginning Cash Position | 5,037 | 5,037 | 5,037 | 5,037 | 7,080 |
| End Cash Position | 7,534 | 10,545 | 4,466 | 1,321 | 5,037 |
| Net Cash Flow | $2,497 | $5,508 | $-571 | $-3,716 | $-2,043 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,885 | -12,375 | -8,875 | -5,769 | -15,278 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -218 |
| Free Cash Flow | -15,885 | -12,375 | -8,875 | -5,769 | -15,496 |